イボガインのマトリックス薬理解読:セロトニンシナプスの複数のトランスポーター調節
Christopher Hwu1, Václav Havel1, Xavier Westergaard2,3
1Department of Chemistry, Columbia University, New York, New York 10027, United States.
Journal of the American Chemical Society
|December 26, 2025
まとめ
イボガインとその代謝産物ノリボガインは,膀性モノアミントランスポーター2 (VMAT2) とセロトニントランスポーター (SERT) を阻害する. "シナプス再吸収阻害剤" (SynRIs) と呼ばれるこの二重作用は,イボガインの
科学分野:
- 神経科学
- 薬理学について
- 生物化学
背景:
- イボガインはイボガの木から派生し,様々な神経学的および精神的疾患の治療の可能性を示しています.
- 作用のメカニズムを理解するには,モノアミンの神経伝達体への影響を調べる必要があります.
研究 の 目的:
- イボガイン,ノリボガイン,イボガイン類のモノアミントランスポーターに対する効果を体系的に調査する.
- イボガインの治療効果の 基礎となる神経化学的メカニズムを解明する
主な方法:
- VMAT2輸送機能を評価するための細胞ベースの光測定法.
- 2光子顕微鏡で マウスの脳内のトランスポーター活動を可視化します
- 放射性標識されたセロトニンを用いて脳シナプス小胞で吸収と放出を測定する.
- SERTとOCT2を含むプラズマ膜モノアミントランスポーター (MAT) の抑制測定
主要な成果:
- イボガインとノリボガインはVMAT2を微小分子の効能で抑制する.
- ノリボガインは,シナプス水泡からセロトニンの部分的な放出を誘導することが判明しました.
- イボガ化合物はSERTとOCT2を阻害し,いくつかの類似体はVMAT2とSERTの二重阻害を示しています.
- これらの二重阻害剤は"シナプス再吸収阻害剤" (SynRIs) と呼ばれた.
結論:
- SynRIプロファイルは,イボガインの神経化学効果と治療の可能性のモデルを提供します.
- この"マトリックス薬理"と呼ばれるイボガインの最新理解は,なぜイボガインが他のVMAT2阻害剤と異なり,カタレプシーを誘発しないかを説明するのに役立ちます.
さらに関連する動画
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.5K
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
15.5K
関連する概念動画
01:23Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
851
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
851
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:26Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K